FIELD: pharmacology.
SUBSTANCE: compositions for tuberculosis treatment include thioacetazone s active ingredient, as well as lactose, starch, talc and stearic acid and/or a salt thereof, at a certain quantitative ratio.
EFFECT: invention allows to obtain a composition characterized by high solubility, bioavailability and efficacy.
8 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 |
|
RU2620857C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
PHARMACEUTICAL COMPOSITIONS OF ANTITUBERCULOSIS MEDICINAL AGENTS AND METHOD FOR THEIR PREPARING | 2001 |
|
RU2240795C9 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
Authors
Dates
2017-08-09—Published
2015-10-30—Filed